Clinical Trial Update: Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST, and Pharmacokinetics/Pharmacodynamics)in Prognosis of Bacteremia by Enterobacteriaceae

View source ↗

Summary

This completed clinical trial studied how minimum inhibitory concentration and susceptible cut-off points (CLS I, EUCAST) influence prognosis in Enterobacteriac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterobacteriaceae Bacteremia

Snippet

Sponsor: Fundación Pública Andaluza Progreso y Salud | Conditions: Bacteremia by Enterobacteriaceae | Status: COMPLETED